CFO  News Hubb
Advertisement
  • Home
  • CFO News
  • Financial Advisor
  • Financial Planning
  • Markets News
  • Economics
  • Contact
No Result
View All Result
  • Home
  • CFO News
  • Financial Advisor
  • Financial Planning
  • Markets News
  • Economics
  • Contact
No Result
View All Result
CFO  News Hubb
No Result
View All Result
Home Markets News

Stocks moving big after hours: DASH, AMAT, DKNG

by admin
February 19, 2023
in Markets News
Stocks moving big after hours: DASH, AMAT, DKNG


Rafael Henrique | LightRocket | Getty Images

Check out the companies making headlines in midday trading.

DoorDash — The online food delivery platform’s shares jumped 7% after it reported a revenue beat and upbeat guidance. The company’s fourth-quarter revenue came in at $1.82 billion, topping the $1.77 billion estimated by analysts polled by Refinitiv. Reported losses, however, were greater than analysts’ projections, coming in at a per-share loss of $1.65 versus analysts’ estimates of 68 cents.

Texas Roadhouse — The restaurant chain’s shares dropped about 5%, coming down from a 52-week high during Thursday’s trading session. Texas Roadhouse’s fourth-quarter earnings and revenue fell below expectations. The restaurant posted 89 cents earnings per share versus the $1.03 estimated by analysts polled by Refinitiv. Revenue came in at $1.01 billion, missing analysts’ estimates of $1.02 billion. The company blamed commodity inflation and higher wages for the shortfall.

DraftKings — The sports betting company’s shares gained 6% after its fourth-quarter earnings and revenue exceeded analysts’ estimates. DraftKings posted a per-share loss of 53 cents and revenue of $855 million. Analysts polled by Refinitiv had anticipated a loss of 53 cents per share and $800 million in revenue.

Applied Materials — The semiconductor company’s stock added about 2% after Applied Materials posted its latest results. The company earned $2.03 per share, excluding items, in the first fiscal quarter, topping a consensus estimate of $1.93 per share, according to Refinitiv. Revenue was $6.74 billion in the same quarter, beating analysts’ estimates of $6.69 billion. Meanwhile, the company lowered its guidance for the second fiscal quarter, citing ongoing supply chain challenges.

Moderna — Shares for the biotech company fell 6.7% after its influenza vaccine candidate posted mixed results in clinical trials.



Source link

Previous Post

Recessions and Economic Freedom | AIER

Next Post

Reading Between the Lines of a C-Suite Job Description

TRENDING

FRC, UBS, FLT, DELL and more
Markets News

FRC, UBS, FLT, DELL and more

March 20, 2023
Economics

Is it a LOLR? No, It’s a Trap

March 20, 2023
Economics

Recent banking failures add another reason to halt interest rate hikes

March 20, 2023
Economics

2:00PM Water Cooler 3/20/2023 | naked capitalism

March 20, 2023
CFO News

ChatGPT Helped Win a Hackathon

March 20, 2023

© 2022 CFO News Hubb All rights reserved.

Use of these names, logos, and brands does not imply endorsement unless specified. By using this site, you agree to the Privacy Policy and Terms & Conditions.

Navigate Site

  • Home
  • CFO News
  • Financial Advisor
  • Financial Planning
  • Markets News
  • Economics
  • Contact

Newsletter Sign Up

No Result
View All Result
  • Home
  • CFO News
  • Financial Advisor
  • Financial Planning
  • Markets News
  • Economics
  • Contact

© 2022 CFO News Hubb All rights reserved.